Printer Friendly

Total or neonatal bilirubin assays in the Vitros 5,1 FS: hemoglobin interference, hemolysis, icterus index.

To the Editor:

We evaluated hemoglobin (Hb) interference in the total bilirubin (TBIL) and neonatal bilirubin (NBIL) [the sum of unconjugated (Bu) and conjugated (Bc) bilirubins] methods on the Vitros 5,1 FS analyzer and assessed the reliability of the analyzer's hemolysis and icterus index values by comparing them to measured concentrations of bilirubin and Hb in test specimens. We also compared TBIL with NBIL values in specimens from neonates 1-14 days old and obtained estimates of the extent of hemolysis in these specimens.

We prepared a hemolysate from EDTA blood drawn from volunteers. After centrifugation, the cells were washed 5 times with physiologic saline, diluted with deionized water, and stored at -20 [degrees]C overnight. After thawing, the hemolysate was centrifuged to remove the stroma. The Hb concentration was measured with the CELL-DYN 4000 analyzer. We prepared a stock solution of Bu (NIST SRM 916) in pooled human serum samples from healthy volunteers as described previously (1); dilutions were made with the same pooled sera.

[FIGURE 1 OMITTED]

A solution of Bc was prepared by adding to pooled human sera a mixture of bilirubin mono- and diglucuronide isolated from human bile (2); the solution was dispensed into vials, lyophilized, and stored at -70 [degrees]C. Vials containing the pooled human sera were also lyophilized. The composition of bilirubin fractions as determined by HPLC was [delta]-bilirubin, 6%; bilirubin monoglucuronide, 34%; bilirubin diglucuronide, 57%; and Bu, 3%. The lyophilized materials were rehydrated on the day of use; dilutions were made with pooled sera.

Three solutions of Bu (concentrations 51-229 mg/L) and the pooled sera were enriched with 4 concentrations of hemolysate (concentrations 1.43-4.65 g/L). Three solutions of Bc and the rehydrated pooled sera were enriched with 4 concentrations of hemolysate and a constant amount of Bu. The presence of Bu is required for obtaining results with the NBIL method. Contrary to our experience, Rosenthal et al. (3) reported that the presence of Bc is required for obtaining Bu results with the NBIL method.

All specimens were analyzed with the Vitros 5,1 FS analyzer for TBIL and NBIL. The TBIL assay is a diazo method that measures the sum of Bu, Bc, and [delta]-bilirubin. The NBIL method is based on direct spectrophotometry and measures Bu and the sum of bilirubin mono- and diglucuronide (Bc), but does not measure [delta]-bilirubin.

Hb interference with the NBIL method was negligible (Fig. 1A). In the TBIL method (Fig. 1B), Hb interference was positive at low bilirubin concentrations and negative at high concentrations, a result attributable to a combination of chemical (4) and spectral (5) interference. In the latter, the absorbance of Hb at low bilirubin concentrations overcompensates for decreased absorbance caused by the destruction of the azobilirubin, whereas at high bilirubin concentrations Hb does not compensate for this decrease.

The hemolysis index, expressed as a percentage of the measured Hb concentration, varied from 92%-107% in the test solutions, a very good agreement. At high Bu concentrations (>200 mg/L) there was no result for this index. In 92 blood specimens from neonates 1-14 days old, the index was <15-49 in 49 specimens, 50-99 in 15,100-199 in 14, and 200-250 in only 2. Numerically this index corresponds very closely to the Hb concentration in mg/dL.

In the presence of both Bc and Bu, the icterus index varied between 92% and 100% of the measured TBIL values of the test solutions. In the presence of only Bu the agreement was not as good. Numerically the index corresponds to milligrams per deciliter bilirubin.

In 92 blood specimens from neonates 1-14 days old, mean values for TBIL and NBIL were 102.8 mg/L and 105.5 mg/L, respectively; the regression equation was

y(NBIL) = 1.050 x (TBIL) - 2.4;

[S.sub.y/x] = 5.4.

This result confirms a previous report (6) that differences between the 2 methods are negligible.

Our results indicate that the TBIL and NBIL methods provide the same results in blood specimens from healthy neonates; thus laboratories should use the method they prefer. In cholestasis TBIL may be higher than NBIL because the latter does not measure [delta]-bilirubin, which, because of its long half-life (17 days), could persist long after hepatitis has subsided or obstruction has been relieved and obscure the clinical picture in patients recovering from hepatobiliary cholestasis. We believe, however, that the NBIL method is superior to TBIL and should be used for all specimens regardless of age because it is free from Hb interference and has the advantage of detecting cholestasis. We also believe that the "<14-day" restriction recommended by the manufacturer, which discourages use of the NBIL method, is unnecessary.

DOI: 10.1373/clinchem.2006.082586

References

(1.) Doumas BT, Poon PKC, Perry BW, Jendrzejczak B, McComb RB, Schaffer R, Hause LL. Candidate reference method for determination of total bilirubin in serum: development and validation. Clin Chem 1985;31:1779-89.

(2.) Lucassen J. The diazo reaction of bilirubin and bilirubin diglucuronide. PhD thesis, Univ. of Utrecht 1961.

(3.) Rosenthal P, Keefe MT, Henton D, Cheng M. Ektachem and unconjugated bilirubin measurements [Letter]. J Clin Chem Clin Biochem 1989; 27:829.

(4.) Shull BC, Lees H, Li PK. Mechanism of interference by hemoglobin in the determination of total bilirubin. II. Method of Jendrassik-Grof. Clin Chem 1980;26:26-9.

(5.) Doumas BT, Wu TW. The measurement of bilirubin fractions in serum. CRC Crit Rev Clin Lab Sciences 1991;28:415-45.

(6.) Langbaum ME, Farber SJ, Rosenthal P. Automated total and neonatal bilirubin values in newborns: is a distinction clinically relevant? Clin Chem 1992;38:1690-3.

Stanley F. Lo [1,2] * Bernadine Jendrzejczak [2] Basil T. Doumas [1]

[1] Department of Pathology Medical College of Wisconsin Milwaukee, WI

[2] Department of Pathology Children's Hospital of Wisconsin Milwaukee, WI

Address correspondence to this author at: Department of Pathology/MS701, Children's Hospital of Wisconsin, 9000 West Wisconsin Ave., Milwaukee, WI 53201. Fax 414-266-2779; e-mail stanlo@mcw.edu.
COPYRIGHT 2007 American Association for Clinical Chemistry, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Letters
Author:Lo, Stanley F.; Jendrzejczak, Bernadine; Doumas, Basil T.
Publication:Clinical Chemistry
Article Type:Letter to the editor
Date:Apr 1, 2007
Words:995
Previous Article:Comparison of calcitonin determinations by polyclonal and monoclonal IRMAs.
Next Article:Very high inhibin A concentration attributed to heterophilic antibody interference.
Topics:


Related Articles
Answering your questions: hemolysis in serologic specimens, infant stool collection and capillary blood for blood gasses. (Tips from the Clinical...
C-Reactive Protein (CRP) in neonates: comparing VITROS slide and high-sensitivity CRP methods.
Considerably reduced centrifugation time without increased hemolysis: evaluation of the new BD Vacutainer[R] SST[TM]II advance.
Hemolysis interference in the ortho-clinical diagnostics vitros ECi cTnI assay.
Effects of hemolysis on the Roche ammonia method for Hitachi analyzers.
Mechanism of interference by hemolysis in immunoassays and requirements for sample quality.
Variability in potassium/hemoglobin ratios for hemolysis correction.
Direct spectrophotometric method for measurement of bilirubin in newborns: comparison with HPLC and an automated diazo method.
Observations on the zinc protoporphyrin/heme ratio in whole blood.
Lipemia interference with a rate-blanked creatinine method.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters